Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Alliacense Attorney to Manage European Licensing Activities

Say MR RG was able to purchase 100 million shares at under 20 cents before the magnitude of how many licensees was understood by the market. And upon realization that there was a ton of money coming in with all the new licensing activity, the share price appreciated to a buck.

What I dont know is if MR RG could use the 100 million shares, now price at a buck, to acquire new companies or are the shares retired.

If the shares are in the treasury, wouldnt you say that would be a great investment.



Share
New Message
Please login to post a reply